Skip to main content
Clinical Trials/CTRI/2022/03/040878
CTRI/2022/03/040878
Not yet recruiting
未知

To study the role of Vitamin D and calcium supplementation on tumor response in patients receiving neoadjuvant chemotherapy for stage II/III breast cancer- A comparative study

King George Medical University UP0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C509- Malignant neoplasm of breast of unspecified siteHealth Condition 2: C501- Malignant neoplasm of central portion of breastHealth Condition 3: C500- Malignant neoplasm of nipple and areolaHealth Condition 4: C508- Malignant neoplasm of overlappingsites of breast
Sponsor
King George Medical University UP
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
King George Medical University UP

Eligibility Criteria

Inclusion Criteria

  • 1\.Naïve Stage II/III breast cancer patients consenting for NACT.

Exclusion Criteria

  • 1\. Patients with osteoporosis and parathyroid disorders.
  • 2\. Patients not consenting for chemotherapy.

Outcomes

Primary Outcomes

Not specified

Similar Trials